Drug Manufacturers - Specialty & Generic
Compare Stocks
4 / 10Stock Comparison
EVO vs LSCC vs AMAT vs IQV
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Medical - Diagnostics & Research
EVO vs LSCC vs AMAT vs IQV — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | Semiconductors | Semiconductors | Medical - Diagnostics & Research |
| Market Cap | $1.08B | $16.43B | $325.54B | $30.32B |
| Revenue (TTM) | $786M | $574M | $28.37B | $16.63B |
| Net Income (TTM) | $-104M | $20M | $7.00B | $1.39B |
| Gross Margin | 14.4% | 66.9% | 48.7% | 26.1% |
| Operating Margin | -8.7% | 5.5% | 29.2% | 13.9% |
| Forward P/E | — | 114.2x | 37.1x | 14.1x |
| Total Debt | $447M | $78M | $6.55B | $16.17B |
| Cash & Equiv. | $418M | $134M | $7.24B | $1.98B |
EVO vs LSCC vs AMAT vs IQV — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Evotec SE (EVO) | 100 | 22.6 | -77.4% |
| Lattice Semiconduct… (LSCC) | 100 | 482.2 | +382.2% |
| Applied Materials, … (AMAT) | 100 | 730.7 | +630.7% |
| IQVIA Holdings Inc. (IQV) | 100 | 119.5 | +19.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EVO vs LSCC vs AMAT vs IQV
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EVO is the clearest fit if your priority is sleep-well-at-night and defensive.
- Lower volatility, beta 1.08, Low D/E 55.0%, current ratio 2.07x
- Beta 1.08, current ratio 2.07x
- Beta 1.08 vs LSCC's 2.48
LSCC is the clearest fit if your priority is long-term compounding.
- 22.1% 10Y total return vs AMAT's 20.1%
AMAT carries the broadest edge in this set and is the clearest fit for income & stability.
- Dividend streak 8 yrs, beta 2.14, yield 0.4%
- 24.7% margin vs EVO's -13.2%
- 0.4% yield; 8-year raise streak; the other 3 pay no meaningful dividend
- +164.7% vs EVO's -26.9%
IQV is the #2 pick in this set and the best alternative if growth exposure and valuation efficiency is your priority.
- Rev growth 5.9%, EPS growth 4.7%, 3Y rev CAGR 4.2%
- PEG 0.35 vs AMAT's 2.16
- 5.9% revenue growth vs EVO's -5.0%
- Lower P/E (14.1x vs 37.1x), PEG 0.35 vs 2.16
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 5.9% revenue growth vs EVO's -5.0% | |
| Value | Lower P/E (14.1x vs 37.1x), PEG 0.35 vs 2.16 | |
| Quality / Margins | 24.7% margin vs EVO's -13.2% | |
| Stability / Safety | Beta 1.08 vs LSCC's 2.48 | |
| Dividends | 0.4% yield; 8-year raise streak; the other 3 pay no meaningful dividend | |
| Momentum (1Y) | +164.7% vs EVO's -26.9% | |
| Efficiency (ROA) | 19.3% ROA vs EVO's -5.3%, ROIC 33.3% vs -10.5% |
EVO vs LSCC vs AMAT vs IQV — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
EVO vs LSCC vs AMAT vs IQV — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMAT leads in 3 of 6 categories
LSCC leads 1 • IQV leads 1 • EVO leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
LSCC leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AMAT is the larger business by revenue, generating $28.4B annually — 49.4x LSCC's $574M. AMAT is the more profitable business, keeping 24.7% of every revenue dollar as net income compared to EVO's -13.2%. On growth, LSCC holds the edge at +42.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $786M | $574M | $28.4B | $16.6B |
| EBITDAEarnings before interest/tax | -$36M | $63M | $8.4B | $3.5B |
| Net IncomeAfter-tax profit | -$104M | $20M | $7.0B | $1.4B |
| Free Cash FlowCash after capex | -$92M | $152M | $5.7B | $2.7B |
| Gross MarginGross profit ÷ Revenue | +14.4% | +66.9% | +48.7% | +26.1% |
| Operating MarginEBIT ÷ Revenue | -8.7% | +5.5% | +29.2% | +13.9% |
| Net MarginNet income ÷ Revenue | -13.2% | +3.5% | +24.7% | +8.3% |
| FCF MarginFCF ÷ Revenue | -11.7% | +26.5% | +20.1% | +16.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.4% | +42.2% | -3.5% | +8.4% |
| EPS Growth (YoY)Latest quarter vs prior year | +137.1% | +3.4% | +13.9% | +15.0% |
Valuation Metrics
IQV leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 22.8x trailing earnings, IQV trades at a 100% valuation discount to LSCC's 5377.6x P/E. Adjusting for growth (PEG ratio), IQV offers better value at 0.56x vs AMAT's 2.76x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.1B | $16.4B | $325.5B | $30.3B |
| Enterprise ValueMkt cap + debt − cash | $1.1B | $16.4B | $324.9B | $44.5B |
| Trailing P/EPrice ÷ TTM EPS | -9.27x | 5377.58x | 47.40x | 22.79x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 114.18x | 37.07x | 14.06x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 2.76x | 0.56x |
| EV / EBITDAEnterprise value multiple | — | 284.32x | 38.68x | 12.97x |
| Price / SalesMarket cap ÷ Revenue | 1.22x | 31.40x | 11.48x | 1.86x |
| Price / BookPrice ÷ Book value/share | 1.13x | 23.22x | 16.25x | 4.67x |
| Price / FCFMarket cap ÷ FCF | — | 123.92x | 57.13x | 14.78x |
Profitability & Efficiency
AMAT leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
AMAT delivers a 34.3% return on equity — every $100 of shareholder capital generates $34 in annual profit, vs $-12 for EVO. LSCC carries lower financial leverage with a 0.11x debt-to-equity ratio, signaling a more conservative balance sheet compared to IQV's 2.44x. On the Piotroski fundamental quality scale (0–9), AMAT scores 7/9 vs IQV's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | -11.5% | +2.8% | +34.3% | +22.1% |
| ROA (TTM)Return on assets | -5.3% | +2.3% | +19.3% | +4.7% |
| ROICReturn on invested capital | -10.5% | +1.8% | +33.3% | +8.7% |
| ROCEReturn on capital employed | -9.1% | +2.0% | +30.6% | +11.0% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 5 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.55x | 0.11x | 0.32x | 2.44x |
| Net DebtTotal debt minus cash | $29M | -$56M | -$686M | $14.2B |
| Cash & Equiv.Liquid assets | $418M | $134M | $7.2B | $2.0B |
| Total DebtShort + long-term debt | $447M | $78M | $6.6B | $16.2B |
| Interest CoverageEBIT ÷ Interest expense | -5.81x | 6.02x | 35.46x | 3.10x |
Total Returns (Dividends Reinvested)
AMAT leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMAT five years ago would be worth $31,383 today (with dividends reinvested), compared to $1,501 for EVO. Over the past 12 months, AMAT leads with a +164.7% total return vs EVO's -26.9%. The 3-year compound annual growth rate (CAGR) favors AMAT at 53.1% vs EVO's -30.2% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -4.1% | +52.5% | +52.9% | -20.7% |
| 1-Year ReturnPast 12 months | -26.9% | +146.9% | +164.7% | +16.5% |
| 3-Year ReturnCumulative with dividends | -65.9% | +41.8% | +258.7% | -5.9% |
| 5-Year ReturnCumulative with dividends | -85.0% | +137.2% | +213.8% | -23.8% |
| 10-Year ReturnCumulative with dividends | +132.9% | +2210.6% | +2014.4% | +166.5% |
| CAGR (3Y)Annualised 3-year return | -30.2% | +12.3% | +53.1% | -2.0% |
Risk & Volatility
Evenly matched — EVO and AMAT each lead in 1 of 2 comparable metrics.
Risk & Volatility
EVO is the less volatile stock with a 1.08 beta — it tends to amplify market swings less than LSCC's 2.48 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMAT currently trades 94.8% from its 52-week high vs EVO's 63.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.08x | 2.48x | 2.14x | 1.33x |
| 52-Week HighHighest price in past year | $4.80 | $127.95 | $432.81 | $247.05 |
| 52-Week LowLowest price in past year | $2.31 | $43.90 | $151.51 | $134.65 |
| % of 52W HighCurrent price vs 52-week peak | +63.5% | +93.7% | +94.8% | +72.3% |
| RSI (14)Momentum oscillator 0–100 | 61.3 | 64.5 | 66.3 | 58.5 |
| Avg Volume (50D)Average daily shares traded | 120K | 1.8M | 6.0M | 1.6M |
Analyst Outlook
AMAT leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: EVO as "Buy", LSCC as "Buy", AMAT as "Buy", IQV as "Buy". Consensus price targets imply 129.5% upside for EVO (target: $7) vs -11.0% for LSCC (target: $107). AMAT is the only dividend payer here at 0.42% yield — a key consideration for income-focused portfolios.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $7.00 | $106.70 | $426.39 | $225.63 |
| # AnalystsCovering analysts | 7 | 17 | 53 | 44 |
| Dividend YieldAnnual dividend ÷ price | — | — | +0.4% | — |
| Dividend StreakConsecutive years of raises | 0 | — | 8 | 2 |
| Dividend / ShareAnnual DPS | — | — | $1.71 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.6% | +1.5% | +4.1% |
AMAT leads in 3 of 6 categories (Profitability & Efficiency, Total Returns). LSCC leads in 1 (Income & Cash Flow). 1 tied.
EVO vs LSCC vs AMAT vs IQV: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EVO or LSCC or AMAT or IQV a better buy right now?
For growth investors, IQVIA Holdings Inc.
(IQV) is the stronger pick with 5. 9% revenue growth year-over-year, versus -5. 0% for Evotec SE (EVO). IQVIA Holdings Inc. (IQV) offers the better valuation at 22. 8x trailing P/E (14. 1x forward), making it the more compelling value choice. Analysts rate Evotec SE (EVO) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EVO or LSCC or AMAT or IQV?
On trailing P/E, IQVIA Holdings Inc.
(IQV) is the cheapest at 22. 8x versus Lattice Semiconductor Corporation at 5377. 6x. On forward P/E, IQVIA Holdings Inc. is actually cheaper at 14. 1x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: IQVIA Holdings Inc. wins at 0. 35x versus Applied Materials, Inc. 's 2. 16x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — EVO or LSCC or AMAT or IQV?
Over the past 5 years, Applied Materials, Inc.
(AMAT) delivered a total return of +213. 8%, compared to -85. 0% for Evotec SE (EVO). Over 10 years, the gap is even starker: LSCC returned +22. 1% versus EVO's +132. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EVO or LSCC or AMAT or IQV?
By beta (market sensitivity over 5 years), Evotec SE (EVO) is the lower-risk stock at 1.
08β versus Lattice Semiconductor Corporation's 2. 48β — meaning LSCC is approximately 129% more volatile than EVO relative to the S&P 500. On balance sheet safety, Lattice Semiconductor Corporation (LSCC) carries a lower debt/equity ratio of 11% versus 2% for IQVIA Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EVO or LSCC or AMAT or IQV?
By revenue growth (latest reported year), IQVIA Holdings Inc.
(IQV) is pulling ahead at 5. 9% versus -5. 0% for Evotec SE (EVO). On earnings-per-share growth, the picture is similar: Evotec SE grew EPS 50. 0% year-over-year, compared to -94. 9% for Lattice Semiconductor Corporation. Over a 3-year CAGR, IQV leads at 4. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EVO or LSCC or AMAT or IQV?
Applied Materials, Inc.
(AMAT) is the more profitable company, earning 24. 7% net margin versus -13. 1% for Evotec SE — meaning it keeps 24. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMAT leads at 29. 2% versus -17. 9% for EVO. At the gross margin level — before operating expenses — LSCC leads at 68. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EVO or LSCC or AMAT or IQV more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, IQVIA Holdings Inc. (IQV) is the more undervalued stock at a PEG of 0. 35x versus Applied Materials, Inc. 's 2. 16x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, IQVIA Holdings Inc. (IQV) trades at 14. 1x forward P/E versus 114. 2x for Lattice Semiconductor Corporation — 100. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EVO: 129. 5% to $7. 00.
08Which pays a better dividend — EVO or LSCC or AMAT or IQV?
In this comparison, AMAT (0.
4% yield) pays a dividend. EVO, LSCC, IQV do not pay a meaningful dividend and should not be held primarily for income.
09Is EVO or LSCC or AMAT or IQV better for a retirement portfolio?
For long-horizon retirement investors, Evotec SE (EVO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1.
08), +132. 9% 10Y return). Applied Materials, Inc. (AMAT) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EVO: +132. 9%, AMAT: +20. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EVO and LSCC and AMAT and IQV?
These companies operate in different sectors (EVO (Healthcare) and LSCC (Technology) and AMAT (Technology) and IQV (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.